Neoadjuvant Therapy for Esophageal Cancer.

Cancers (Basel) · 2026 · PMC12984185 · PMID 41827686

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

(2023), including 4 randomized control trials (n = 497), reported an absolute 5-year survival benefit of 0.9 months for nCRT compared to nCT, although this did not reach statistical significance [ 19 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.